| 标题 |
[高分]
Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Neurology 作者:Giuseppe Plazzi; Ronald R Grunstein; Emmanuel Mignot; Gert Jan Lammers; David T Plante; et al 出版日期:2026-10-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)